Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2016

01-08-2016 | Original Article

Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients

Authors: Yu-Ming Chang, Chih-Chung Shiao, Kuo-Chi Chang, I-Ling Chen, Chuan-Lan Yang, Show-Chin Leu, Hung-Li Su, Jsun-Liang Kao, Shih-Ching Tsai, Rong-Na Jhen

Published in: Clinical and Experimental Nephrology | Issue 4/2016

Login to get access

Abstract

Background

Intradialytic hypotension (IDH) carries adverse impact. Heart rate variability (HRV) represents autonomic cardiac regulation which influences intradialytic blood pressure. We aimed to evaluate the association between IDH and HRV.

Methods

This prospective study was carried out in a teaching hospital in Taiwan from June to August 2010. Adult patients on chronic hemodialysis without active medical conditions were enrolled and received HRV measurements for 4 times (before and during an index hemodialysis session). Patients were categorized by the changes of systolic blood pressure during the index hemodialysis into Group 1 (elevation >20 mmHg), Group 2 (decrease >20 mmHg), and Group 3 (others). Then we compared HRV indices among the three groups, and determined the indicators for IDH.

Results

One hundred and seventy-one patients (96 women, mean age 64.9 years) were enrolled and categorized into Group 1 (n = 47, 27.5 %), Group 2 (n = 45, 26.3 %) and Group 3 (n = 79, 46.2 %). Comparing with Group 1 and/or Group 3, Group 2 had significantly higher blood pressure at hemodialysis initiation (most p < 0.001) and statistically lower levels of HRV indices including variance, total power, very low-frequency, low-frequency and high-frequency since the middle phase of the hemodialysis. By logistic regression method, higher systemic blood pressure [odds ratio (OR) 1.048; p < 0.001], heart rate (OR 1.093; p = 0.021), low-frequency/high-frequency ratio (OR 1.715; p = 0.022), as well as lower variance (OR 0.639; p = 0.048) at hemodialysis initiation were independently associated with intradialytic blood pressure changes.

Conclusions

HRV is a useful indicator for IDH among hemodialysis patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–153.
2.
go back to reference Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron. 1975;15(6):424–9.CrossRefPubMed Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron. 1975;15(6):424–9.CrossRefPubMed
3.
go back to reference Daul AE, Wang XL, Michel MC, Brodde OE. Arterial hypotension in chronic hemodialyzed patients. Kidney Int. 1987;32(5):728–35.CrossRefPubMed Daul AE, Wang XL, Michel MC, Brodde OE. Arterial hypotension in chronic hemodialyzed patients. Kidney Int. 1987;32(5):728–35.CrossRefPubMed
5.
go back to reference Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol. 1999;10(12):2577–84.PubMed Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol. 1999;10(12):2577–84.PubMed
6.
go back to reference Routledge HC, Chowdhary S, Townend JN. Heart rate variability—a therapeutic target? J Clin Pharm Ther. 2002;27(2):85–92.CrossRefPubMed Routledge HC, Chowdhary S, Townend JN. Heart rate variability—a therapeutic target? J Clin Pharm Ther. 2002;27(2):85–92.CrossRefPubMed
9.
go back to reference Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Euro Heart J. 1996;17(3):354–81. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Euro Heart J. 1996;17(3):354–81.
11.
go back to reference Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Lond). 1999;96(1):23–31.CrossRef Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, et al. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Lond). 1999;96(1):23–31.CrossRef
12.
14.
go back to reference Chen KY, Chen CL, Yang CC, Kuo TB. Cardiac autonomic dysregulation in patients with acute hepatitis. Am J Med Sci. 2006;332(4):164–7.CrossRefPubMed Chen KY, Chen CL, Yang CC, Kuo TB. Cardiac autonomic dysregulation in patients with acute hepatitis. Am J Med Sci. 2006;332(4):164–7.CrossRefPubMed
15.
go back to reference Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997;92(4):351–9.CrossRef Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, et al. Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997;92(4):351–9.CrossRef
16.
go back to reference Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004;19(8):2053–60. doi:10.1093/ndt/gfh306.CrossRefPubMed Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D. Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004;19(8):2053–60. doi:10.​1093/​ndt/​gfh306.CrossRefPubMed
17.
go back to reference Forsstrom J, Heinonen E, Valimaki I, Antila K. Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest. 1986;46(7):665–70.CrossRefPubMed Forsstrom J, Heinonen E, Valimaki I, Antila K. Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest. 1986;46(7):665–70.CrossRefPubMed
19.
go back to reference Ino-Oka E, Urae J, Sekino M, Satoh M, Takeuchi K, Sekino H, et al. Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction. Intern Med. 2011;50(22):2741–8.CrossRefPubMed Ino-Oka E, Urae J, Sekino M, Satoh M, Takeuchi K, Sekino H, et al. Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction. Intern Med. 2011;50(22):2741–8.CrossRefPubMed
20.
go back to reference Cases A, Coll E. Chronic hypotension in the dialysis patient. J Nephrol. 2002;15(4):331–5.PubMed Cases A, Coll E. Chronic hypotension in the dialysis patient. J Nephrol. 2002;15(4):331–5.PubMed
21.
22.
go back to reference Yamamoto K, Kobayashi N, Kutsuna T, Ishii A, Matsumoto T, Hara M, et al. Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity. Ther Apher Dial. 2012;16(3):219–25. doi:10.1111/j.1744-9987.2011.01053.x.CrossRefPubMed Yamamoto K, Kobayashi N, Kutsuna T, Ishii A, Matsumoto T, Hara M, et al. Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity. Ther Apher Dial. 2012;16(3):219–25. doi:10.​1111/​j.​1744-9987.​2011.​01053.​x.CrossRefPubMed
23.
26.
27.
go back to reference Kim YH, Ahmed MW, Kadish AH, Goldberger JJ. Characterization of the factors that determine the effect of sympathetic stimulation on heart rate variability. Pacing Clin Electrophysiol (PACE). 1997;20(8 Pt 1):1936–46.CrossRef Kim YH, Ahmed MW, Kadish AH, Goldberger JJ. Characterization of the factors that determine the effect of sympathetic stimulation on heart rate variability. Pacing Clin Electrophysiol (PACE). 1997;20(8 Pt 1):1936–46.CrossRef
29.
go back to reference Yun JS, Ahn YB, Song KH, Yoo KD, Kim HW, Park YM, et al. The association between abnormal heart rate variability and a new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study. Diabetes Res Clin Pract. 2015;. doi:10.1016/j.diabres.2015.01.031.PubMed Yun JS, Ahn YB, Song KH, Yoo KD, Kim HW, Park YM, et al. The association between abnormal heart rate variability and a new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study. Diabetes Res Clin Pract. 2015;. doi:10.​1016/​j.​diabres.​2015.​01.​031.PubMed
30.
go back to reference Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–6.CrossRefPubMed Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–6.CrossRefPubMed
31.
go back to reference Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88(1):180–5.CrossRefPubMed Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation. 1993;88(1):180–5.CrossRefPubMed
32.
go back to reference Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008;57(4):200–5. doi:10.1159/000149818.CrossRefPubMed Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology. 2008;57(4):200–5. doi:10.​1159/​000149818.CrossRefPubMed
33.
go back to reference Castellanos A, Moleiro F, Chakko S, Acosta H, Huikuri H, Mitrani RD, et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol. 1998;82(4):531–4.CrossRefPubMed Castellanos A, Moleiro F, Chakko S, Acosta H, Huikuri H, Mitrani RD, et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol. 1998;82(4):531–4.CrossRefPubMed
34.
go back to reference Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.CrossRefPubMed Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.CrossRefPubMed
35.
go back to reference Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol. 2002;282(1):H6–20.PubMed Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol. 2002;282(1):H6–20.PubMed
Metadata
Title
Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients
Authors
Yu-Ming Chang
Chih-Chung Shiao
Kuo-Chi Chang
I-Ling Chen
Chuan-Lan Yang
Show-Chin Leu
Hung-Li Su
Jsun-Liang Kao
Shih-Ching Tsai
Rong-Na Jhen
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2016
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-015-1189-9

Other articles of this Issue 4/2016

Clinical and Experimental Nephrology 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.